Abiopharma

🔍 Long Nicholas T. (Director)

Company: WOLVERINE WORLD WIDE INC /DE/ (WWW)

Report Date: 2026-05-01

Detailed Transactions and Holdings:

• Acquired 127 shares of Stock Units (Derivative)
  Date: 2026-05-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 22,171.73 | transaction_form_type: 4 | Footnotes: F1, F1, F1

Footnotes:

• F1: Award of stock units representing dividend equivalents on amounts previously deferred under the Company's Amended and Restated Outside Directors' Deferred Compensation Plan. Shares of Common Stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Issuer.